Randall Hawkins, MD, PhD



Randall Hawkins, MD, PhD, is a Professor in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. Dr. Hawkins previously served as Program Chief of the Nuclear Medicine Section at UCSF from 1993-2009. He earned his MD from the University of California, Irvine in 1975, and completed a fellowship in Medical Physics from the University of California, Berkeley in 1975. Dr. Hawkins completed a residency in Radiology from the University of Southern California Medical Center in 1979, a residency in Nuclear Medicine from UCLA in 1981, and a Chief residency in Nuclear Medicine from UCLA in 1981. He obtained his MS in Medical Physics from UCLA in 1981, followed by a PhD in Biomedical Physics from UCLA in 1985.

Dr. Hawkins’s research interests are focused on clinical and methodological developments and applications of PET, SPECT, and other imaging modalities in disease states such as cancer, selected work in pathologic, and physiologic investigations of the central nervous system, cardiovascular system and other organ systems. Dr. Hawkins performed the first successful quantitative kinetic PET imaging evaluation of mice. Others followed with the development of micro PET and micro PET/CT scanners, which is now a part of the imaging research environment.

Dr. Hawkins is the lead investigator of a project that was the first to use whole body PET clinical examinations. He has served as Principal Investigator and Co-Principal Investigator for several NIH grants, and he has published 142 articles, 11 book chapter, with 4 significant publications.

Nuclear Medicine

PET imaging, SPECT

Professional Interests:
Nuclear medicine, radiology, positron emission tomography, cancer, brain, heart

Education and Training:
• Medical School: University of California, Irvine
• Internship: University of Southern California Medical Center, Los Angeles - Medicine
• Residency: University of Southern California Medical Center - Radiology
• Residency: University of California, Los Angeles - Nuclear Medicine
• Fellowship: University of California, Berkeley - Medical Physics
• Masters of Science: University of California, Los Angeles - Medical Physics
• Doctor of Philosophy: University of California, Los Angeles - Biomedical Physics
• California Medical License
• Ohio Medical License (inactive)
• American Board of Radiology (ABR)
• American Board of Nuclear Medicine (ABNM)


Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK. Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma. Pediatr Blood Cancer. 2018 May; 65(5):e26940.
Behr SC, Bahroos E, Hawkins RA, Nardo L, Ravanfar V, Capbarat EV, Seo Y. Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI. Mol Imaging Biol. 2017 Nov 30.
Ronald JA, Kim BS, Gowrishankar G, Namavari M, Alam IS, D'Souza A, Nishikii H, Chuang HY, Ilovich O, Lin CF, Reeves R, Shuhendler A, Hoehne A, Chan CT, Baker J, Yaghoubi SS, VanBrocklin HF, Hawkins R, Franc BL, Jivan S, Slater JB, Verdin EF, Gao KT, Benjamin J, Negrin R, Gambhir SS. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. Cancer Res. 2017 06 01; 77(11):2893-2902.
Arentson-Lantz EJ, Saeed IH, Frassetto LA, Masharani U, Harnish RJ, Seo Y, VanBrocklin HF, Hawkins RA, Mari-Aparici C, Pampaloni MH, Slater J, Paddon-Jones D, Lang TF. 11C-L-methyl methionine dynamic PET/CT of skeletal muscle: response to protein supplementation compared to L-[ring 13C6] phenylalanine infusion with serial muscle biopsy. Ann Nucl Med. 2017 May; 31(4):295-303.
Franc BL, Goth S, MacKenzie J, Li X, Blecha J, Lam T, Jivan S, Hawkins RA, VanBrocklin H. In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis. Mol Imaging. 2017 Jan 01; 16:1536012117712638.
Behr SC, Mollard BJ, Yang J, Flavell RR, Hawkins RA, Seo Y. Effect of Time-of-Flight and Regularized Reconstructions on Quantitative Measurements and Qualitative Assessments in Newly Diagnosed Prostate Cancer With 18F-Fluorocholine Dual Time Point PET/MRI. Mol Imaging. 2017 Jan-Dec; 16:1536012117736703.
Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP. Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol. 2016 Dec; 7(6):860-874.
Li R, Polishchuk A, DuBois S, Hawkins R, Lee SW, Bagatell R, Shusterman S, Hill-Kayser C, Al-Sayegh H, Diller L, Haas-Kogan DA, Matthay KK, London WB, Marcus KJ. Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):270-277.
Barajas RF, Krohn KA, Link JM, Hawkins RA, Clarke JL, Pampaloni MH, Cha S. Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine. Biomedicines. 2016 Oct 31; 4(4).
Monteith TS, Kralik SF, Dillon WP, Hawkins RA, Goadsby PJ. The utility of radioisotope cisternography in low CSF/volume syndromes compared to myelography. Cephalalgia. 2016 Nov; 36(13):1291-1295.
Schankin CJ, Maniyar FH, Seo Y, Kori S, Eller M, Chou DE, Blecha J, Murphy ST, Hawkins RA, Sprenger T, VanBrocklin HF, Goadsby PJ. Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain. 2016 07; 139(Pt 7):1994-2001.
DuBois SG, Marachelian A, Fox E, Kudgus RA, Reid JM, Groshen S, Malvar J, Bagatell R, Wagner L, Maris JM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Matthay KK, Mosse YP. Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial. J Clin Oncol. 2016 Apr 20; 34(12):1368-75.
Powles T, Brown J, Larkin J, Jones R, Ralph C, Hawkins R, Chowdhury S, Boleti E, Bhal A, Fife K, Webb A, Crabb S, Geldart T, Hill R, Dunlop J, Hall PE, McLaren D, Ackerman C, Beltran L, Nathan P. A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Ann Oncol. 2016 05; 27(5):880-6.
Kleis MA, Daldrup-Link H, Goldsby R, Hawkins RA, Franc BL. Multiple Scalp Lesions in a Patient with Keratitis, Ichthyosis and Deafness Syndrome Mimicking Metastatic Squamous Cell Carcinoma on 18F-FDG PET/CT. Radiol Case Rep. 2009; 4(2):218.
Aparici CM, Bains SN, Carlson D, Qian J, Liou D, Wojciechowski D, Werner J, Khan S, Kroll C, Sandhu M, Nguyen N, Hawkins R. Recovery of Native Renal Function in Patients with Hepatorenal Syndrome Following Combined Liver and Kidney Transplant with Mercaptoacetyltriglycine-3 Renogram: Developing a Methodology. World J Nucl Med. 2016 Jan-Apr; 15(1):44-9.
Flavell RR, Naeger DM, Aparici CM, Hawkins RA, Pampaloni MH, Behr SC. Malignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance: Resident and Fellow Education Feature. Radiographics. 2016 Jan-Feb; 36(1):293-4.
Lee JS, Wu R, Wong T, DuBois SG, Matthay K, Gustafson C, Hawkins R, Roy-Burman A. Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma. Pediatr Blood Cancer. 2016 Mar; 63(3):471-8.
Trieu M, DuBois SG, Pon E, Nardo L, Hawkins RA, Marachelian A, Twist CJ, Park JR, Matthay KK. Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG). Pediatr Blood Cancer. 2016 Mar; 63(3):436-42.
Wagstaff J, Jones R, Hawkins R, Porfiri E, Pickering L, Bahl A, Brown J, Buchan S. Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry. Ann Oncol. 2016 Jan; 27(1):159-65.
Huang SY, Bolch WE, Lee C, Van Brocklin HF, Pampaloni MH, Hawkins RA, Sznewajs A, DuBois SG, Matthay KK, Seo Y. Patient-specific dosimetry using pretherapy [¹²4I]m-iodobenzylguanidine ([¹²4I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma. Mol Imaging Biol. 2015 Apr; 17(2):284-94.
Barajas RF, Pampaloni MH, Clarke JL, Seo Y, Savic D, Hawkins RA, Behr SC, Chang SM, Berger M, Dillon WP, Cha S. Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma. Case Rep Radiol. 2015; 2015:731361.
DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Villablanca JG, Marachelian A, Matthay KK. Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2015 Jun 15; 21(12):2715-21.
Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, Haas-Koga D, Hasenauer CB, Czarnecki S, Katzenstein HM, Matthay KK. 131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study. Biol Blood Marrow Transplant. 2015 Apr; 21(4):673-81.
DuBois SG, Allen S, Bent M, Hilton JF, Hollinger F, Hawkins R, Courtier J, Mosse YP, Matthay KK. Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma. Br J Cancer. 2015 Feb 17; 112(4):644-9.
Bucknor MD, Rieke V, Seo Y, Horvai AE, Hawkins RA, Majumdar S, Link TM, Saeed M. Bone remodeling after MR imaging-guided high-intensity focused ultrasound ablation: evaluation with MR imaging, CT, Na(18)F-PET, and histopathologic examination in a swine model. Radiology. 2015 Feb; 274(2):387-94.
Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80.
Polishchuk AL, Li R, Hill-Kayser C, Little A, Hawkins RA, Hamilton J, Lau M, Tran HC, Strahlendorf C, Lemons RS, Weinberg V, Matthay KK, DuBois SG, Marcus KJ, Bagatell R, Haas-Kogan DA. Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):839-45.
Bolouri MS, Elias SG, Wisner DJ, Behr SC, Hawkins RA, Suzuki SA, Banfield KS, Joe BN, Hylton NM. Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging. Radiology. 2013 Nov; 269(2):354-61.
Wong T, Matthay KK, Boscardin WJ, Hawkins RA, Brakeman PR, DuBois SG. Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG). Pediatr Blood Cancer. 2013 Sep; 60(9):1424-30.
French S, DuBois SG, Horn B, Granger M, Hawkins R, Pass A, Plummer E, Matthay K. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma. Pediatr Blood Cancer. 2013 May; 60(5):879-84.
Roy A, Cunningham D, Hawkins R, Sörbye H, Adenis A, Barcelo JR, Lopez-Vivanco G, Adler G, Canon JL, Lofts F, Castanon C, Fonseca E, Rixe O, Aparicio J, Cassinello J, Nicolson M, Mousseau M, Schalhorn A, D'Hondt L, Kerger J, Hossfeld DK, Garcia Giron C, Rodriguez R, Schoffski P, Misset JL. Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study. Br J Cancer. 2012 Jul 24; 107(3):435-41.
Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich J. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial. J Nucl Med. 2012 Jul; 53(7):1155-63.
Porzig A, Matthay KK, Dubois S, Pampaloni M, Damon L, Hawkins R, Goldsby R, Hollinger F, Fitzgerald P. Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG). Horm Metab Res. 2012 Jun; 44(7):539-42.
DuBois SG, Chesler L, Groshen S, Hawkins R, Goodarzian F, Shimada H, Yanik G, Tagen M, Stewart C, Mosse YP, Maris JM, Tsao-Wei D, Marachelian A, Villablanca JG, Matthay KK. Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial. Clin Cancer Res. 2012 May 01; 18(9):2679-86.
Aparici CM, Carlson D, Nguyen N, Hawkins RA, Seo Y. Combined SPECT and Multidetector CT for Prostate Cancer Evaluations. Am J Nucl Med Mol Imaging. 2012; 2(1):48-54.
Gawande RS, Khurana A, Messing S, Zhang D, Castañeda RT, Goldsby RE, Hawkins RA, Daldrup-Link HE. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology. 2012 Feb; 262(2):613-22.
Kumar R, Hawkins RA, Yeh BM, Wang ZJ. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant? Nucl Med Commun. 2011 Sep; 32(9):802-7.
Seo Y, Aparici CM, Chen CP, Hsu C, Kased N, Schreck C, Costouros N, Hawkins R, Shinohara K, Roach Iii M. Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT. J Nucl Med. 2011 Jul; 52(7):1068-72.
Polishchuk AL, Dubois SG, Haas-Kogan D, Hawkins R, Matthay KK. Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults. Cancer. 2011 Sep 15; 117(18):4286-93.
Quach A, Ji L, Mishra V, Sznewajs A, Veatch J, Huberty J, Franc B, Sposto R, Groshen S, Wei D, Fitzgerald P, Maris JM, Yanik G, Hawkins RA, Villablanca JG, Matthay KK. Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Pediatr Blood Cancer. 2011 Feb; 56(2):191-201.
Lee CL, Wahnishe H, Sayre GA, Cho HM, Kim HJ, Hernandez-Pampaloni M, Hawkins RA, Dannoon SF, VanBrocklin HF, Itsara M, Weiss WA, Yang X, Haas-Kogan DA, Matthay KK, Seo Y. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET. Med Phys. 2010 Sep; 37(9):4861-7.
Rossi JF, Négrier S, James ND, Kocak I, Hawkins R, Davis H, Prabhakar U, Qin X, Mulders P, Berns B. A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer. Br J Cancer. 2010 Oct 12; 103(8):1154-62.
Seo Y, Aparici CM, Cooperberg MR, Konety BR, Hawkins RA. In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT. J Nucl Med. 2010 Jan; 51(1):31-6.
Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. 2009 Nov 17; 73(20):1662-9.
Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. J Clin Oncol. 2009 Nov 10; 27(32):5343-9.
Kebebew E, Lindsay S, Clark OH, Woeber KA, Hawkins R, Greenspan FS. Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer. Thyroid. 2009 Sep; 19(9):953-6.
Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol. 2009 Sep 01; 27(25):4162-8.
Matthay KK, Quach A, Huberty J, Franc BL, Hawkins RA, Jackson H, Groshen S, Shusterman S, Yanik G, Veatch J, Brophy P, Villablanca JG, Maris JM. Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study. J Clin Oncol. 2009 Mar 01; 27(7):1020-5.
Wagner LM, Villablanca JG, Stewart CF, Crews KR, Groshen S, Reynolds CP, Park JR, Maris JM, Hawkins RA, Daldrup-Link HE, Jackson HA, Matthay KK. Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study. J Clin Oncol. 2009 Mar 10; 27(8):1290-6.
Chau I, Norman AR, Cunningham D, Oates J, Hawkins R, Iveson T, Nicolson M, Harper P, Seymour M, Hickish T. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials. Ann Oncol. 2009 May; 20(5):885-91.
Badiee S, Franc BL, Webb EM, Chu B, Hawkins RA, Coakley F, Singer L. Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. AJR Am J Roentgenol. 2008 Nov; 191(5):1436-9.
Kleis M, Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA, Franc BL. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging. 2009 Jan; 36(1):23-36.
Daldrup-Link HE, Hawkins RA, Meier R, Goldsby RE, Artemov D. Receptor imaging of pediatric tumors: clinical practice and new developments. Pediatr Radiol. 2008 Nov; 38(11):1154-61.
Lee TJ, Glastonbury CM, Buckley AF, Eisele DW, Hawkins RA. Perineural spread of melanoma demonstrated by F-18 FDG PET With MRI and pathologic correlation. Clin Nucl Med. 2008 Feb; 33(2):106-8.
Franc BL, Hawkins RA. Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient. Semin Roentgenol. 2007 Oct; 42(4):265-79.
Purcell DD, Coakley FV, Franc BL, Hawkins RA, Boddington SE, Yeh BM. Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause. AJR Am J Roentgenol. 2007 Aug; 189(2):W96-9.
Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, Hasegawa BH, Hawkins RA, Franc BL. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med. 2007 May; 48(5):802-10.
Falk MS, Truitt AK, Coakley FV, Kashani-Sabet M, Hawkins RA, Franc B. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. Nucl Med Commun. 2007 Apr; 28(4):273-80.
Matthay KK, Yanik G, Messina J, Quach A, Huberty J, Cheng SC, Veatch J, Goldsby R, Brophy P, Kersun LS, Hawkins RA, Maris JM. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. J Clin Oncol. 2007 Mar 20; 25(9):1054-60.
Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA, Matthay KK. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatr Blood Cancer. 2006 Dec; 47(7):865-74.
Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Ann N Y Acad Sci. 2006 Aug; 1073:465-90.
Seo Y, Franc BL, Hawkins RA, Wong KH, Hasegawa BH. Progress in SPECT/CT imaging of prostate cancer. Technol Cancer Res Treat. 2006 Aug; 5(4):329-36.
Seo Y, Wong KH, Sun M, Franc BL, Hawkins RA, Hasegawa BH. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. J Nucl Med. 2005 May; 46(5):868-77.
Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005 Apr; 184(4):1199-204.
Howard JP, Maris JM, Kersun LS, Huberty JP, Cheng SC, Hawkins RA, Matthay KK. Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma. Pediatr Blood Cancer. 2005 Mar; 44(3):232-9.
DuBois SG, Messina J, Maris JM, Huberty J, Glidden DV, Veatch J, Charron M, Hawkins R, Matthay KK. Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma. J Clin Oncol. 2004 Jun 15; 22(12):2452-60.
Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, Hawkins RA, Webb WR. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics. 2004 Jan-Feb; 24(1):105-19.
Weiss B, Vora A, Huberty J, Hawkins RA, Matthay KK. Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma. J Pediatr Hematol Oncol. 2003 Jul; 25(7):543-7.
Hasegawa BH, Wong KH, Iwata K, Barber WC, Hwang AB, Sakdinawat AE, Ramaswamy M, Price DC, Hawkins RA. Dual-modality imaging of cancer with SPECT/CT. Technol Cancer Res Treat. 2002 Dec; 1(6):449-58.
Hawkins RA, Tesdale AL, Prescott RJ, Forster T, McIntyre MA, Baker P, Jack WJ, Chetty U, Dixon JM, Killen ME, Hulme MJ, Miller WR. Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index. Br J Cancer. 2002 Jul 01; 87(1):8-14.
Pham KH, Ramaswamy MR, Hawkins RA. Advances in positron emission tomography imaging for the GI tract. Gastrointest Endosc. 2002 Jun; 55(7 Suppl):S53-63.
Wong ST, Hoo KS, Knowlton RC, Laxer KD, Cao X, Hawkins RA, Dillon WP, Arenson RL. Design and applications of a multimodality image data warehouse framework. J Am Med Inform Assoc. 2002 May-Jun; 9(3):239-54.
Matthay KK, Panina C, Huberty J, Price D, Glidden DV, Tang HR, Hawkins RA, Veatch J, Hasegawa B. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med. 2001 Nov; 42(11):1713-21.
Knowlton RC, Laxer KD, Klein G, Sawrie S, Ende G, Hawkins RA, Aassar OS, Soohoo K, Wong S, Barbaro N. In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology. 2001 Oct 09; 57(7):1184-90.
Tang HR, Da Silva AJ, Matthay KK, Price DC, Huberty JP, Hawkins RA, Hasegawa BH. Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG. J Nucl Med. 2001 Feb; 42(2):237-47.
Schneider DB, Clary-Macy C, Challa S, Sasse KC, Merrick SH, Hawkins R, Caputo G, Jablons D. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2000 Jul; 120(1):128-33.
Challa S, Botvinick EH, Neymark E, Price D, Hawkins RA. An unusual presentation of non-Hodgkin's lymphoma: a case report. Clin Nucl Med. 2000 Feb; 25(2):150-1.
Yu KK, Hawkins RA. The prostate: diagnostic evaluation of metastatic disease. Radiol Clin North Am. 2000 Jan; 38(1):139-57, ix.
Shadan S, Challa S, Hawkins RA. Unusual appearance of thromboembolism on perfusion lung imaging. Clin Nucl Med. 1999 Sep; 24(9):684-6.
Choi Y, Huang SC, Hawkins RA, Kim JY, Kim BT, Hoh CK, Chen K, Phelps ME, Schelbert HR. Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. J Nucl Med. 1999 Jun; 40(6):1045-55.
AAssar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, Dillon WP, Hawkins RA. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology. 1999 Jan; 210(1):177-81.
Langdon SP, Gabra H, Bartlett JM, Rabiaz GJ, Hawkins RA, Tesdale AL, Ritchie AA, Miller WR, Smyth JF. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. Clin Cancer Res. 1998 Sep; 4(9):2245-51.
Dunn SE, Ehrlich M, Sharp NJ, Reiss K, Solomon G, Hawkins R, Baserga R, Barrett JC. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 1998 Aug 01; 58(15):3353-61.
Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, Dillon WP, Hawkins RA. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol. 1998 Aug; 19(7):1189-96.
Knowlton RC, Laxer KD, Ende G, Hawkins RA, Wong ST, Matson GB, Rowley HA, Fein G, Weiner MW. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol. 1997 Dec; 42(6):829-37.
Nelson SJ, Huhn S, Vigneron DB, Day MR, Wald LL, Prados M, Chang S, Gutin PH, Sneed PK, Verhey L, Hawkins RA, Dillon WP. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. J Magn Reson Imaging. 1997 Nov-Dec; 7(6):1146-52.
Nelson SJ, Day MR, Buffone PJ, Wald LL, Budinger TF, Hawkins R, Dillon WP, Huhn S, Prados MD, Chang S, Vigneron DB. Alignment of volume MR images and high resolution [18F]fluorodeoxyglucose PET images for the evaluation of patients with brain tumors. J Comput Assist Tomogr. 1997 Mar-Apr; 21(2):183-91.
Schomberg PJ, Shanahan TG, Ingle JN, Donohue JH, Kuske RR, Sternfeld WC, Wold L, Cha SS, Petersen IA, Brindle JS, Halyard MY, Bollinger JW, Hawkins R, Pisansky TM. Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study. Radiology. 1997 Feb; 202(2):565-9.
Cameron DA, Anderson ED, Levack P, Hawkins RA, Anderson TJ, Leonard RC, Forrest AP, Chetty U. Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy. Br J Cancer. 1997; 76(8):1099-105.
Hawkins RA, Tesdale AL, Killen ME, Jack WJ, Chetty U, Dixon JM, Hulme MJ, Prescott RJ, McIntyre MA, Miller WR. Prospective evaluation of prognostic factors in operable breast cancer. Br J Cancer. 1996 Nov; 74(9):1469-78.
Ho-Shon K, Feng D, Hawkins RA, Meikle S, Fulham MJ, Li X. Optimized sampling and parameter estimation for quantification in whole body PET. IEEE Trans Biomed Eng. 1996 Oct; 43(10):1021-8.
Wu HM, Hoh CK, Huang SC, Yao WJ, Phelps ME, Hawkins RA. Quantification of serial tumor glucose metabolism. J Nucl Med. 1996 Mar; 37(3):506-13.
Langdon SP, Rabiasz GJ, Hirst GL, King RJ, Hawkins RA, Smyth JF, Miller WR. Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res. 1995 Dec; 1(12):1603-9.
Wu HM, Hoh CK, Buxton DB, Kuhle WG, Schelbert HR, Choi Y, Hawkins RA, Phelps ME, Huang SC. Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structures. J Nucl Med. 1995 Nov; 36(11):2087-93.
Wu HM, Hoh CK, Choi Y, Schelbert HR, Hawkins RA, Phelps ME, Huang SC. Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med. 1995 Sep; 36(9):1714-22.
Gabra H, Langdon SP, Watson JE, Hawkins RA, Cohen BB, Taylor L, Mackay J, Steel CM, Leonard RC, Smyth JF. Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer. Clin Cancer Res. 1995 Sep; 1(9):945-53.
Katzenellenbogen JA, Coleman RE, Hawkins RA, Krohn KA, Larson SM, Mendelsohn J, Osborne CK, Piwnica-Worms D, Reba RC, Siegel BA. Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations. Clin Cancer Res. 1995 Aug; 1(8):921-32.
Hawkins RA. Pancreatic tumors: imaging with PET. Radiology. 1995 May; 195(2):320-2.
Yao WJ, Hoh CK, Hawkins RA, Glaspy JA, Weil JA, Lee SJ, Maddahi J, Phelps ME. Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med. 1995 May; 36(5):794-9.
Wu HM, Huang SC, Choi Y, Hoh CK, Hawkins RA. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue. J Nucl Med. 1995 Feb; 36(2):297-306.
Wahl RL, Hawkins RA, Larson SM, Hendee WR, Coleman RE, Holden RW, Frick MP, Gatsonis C, Brown GS, Shtern F. Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda. Radiology. 1994 Dec; 193(3):604-6.
Hoffman JM, Lee A, Grafton ST, Bellamy P, Hawkins RA, Webber M. Clinical signs and symptoms in pulmonary embolism. A reassessment. Clin Nucl Med. 1994 Sep; 19(9):803-8.
Hawkins RA, Hoh CK. PET FDG studies in oncology. Nucl Med Biol. 1994 Jul; 21(5):739-47.
Choi Y, Hawkins RA, Huang SC, Brunken RC, Hoh CK, Messa C, Nitzsche EU, Phelps ME, Schelbert HR. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. J Nucl Med. 1994 May; 35(5):818-23.
Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res. 1994 Apr; 16(2):93-6.
Tse N, Hoh C, Hawkins R, Phelps M, Glaspy J. Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma. Am J Clin Oncol. 1994 Feb; 17(1):22-5.
Karademir S, Csete ME, Jurim O, Finstad T, Hawkins R, Bussuttil RW, Shaked A. Role of 99mTc-labeled DISIDA scan in the assessment of marginal liver grafts after orthotopic transplantation. Clin Transplant. 1994 Feb; 8(1):54-8.
Brunken RC, Mody FV, Hawkins RA, Nienaber CA, Phelps ME, Schelbert HR. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability. Herz. 1994 Feb; 19(1):28-41.
Hawkins RA, Hoh C, Glaspy J, Rege S, Choi Y, Phelps ME. Positron emission tomography scanning in cancer. Cancer Invest. 1994; 12(1):74-87.
Hoh CK, Dahlbom M, Hawkins RA, Glaspy JA, Yao WJ, Lee SJ, Maddahi J, Phelps ME. Basic principles of positron emission tomography in oncology: quantitation and whole body techniques. Wien Klin Wochenschr. 1994; 106(15):496-504.
Rege SD, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, Juillard G, Maddahi J, Phelps ME, Hawkins RA. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology. 1993 Dec; 189(3):807-12.
Choi Y, Huang SC, Hawkins RA, Hoh CK, Krivokapich J, Buxton DB, Armbrecht JJ, Sun KT, Phelps ME, Schelbert HR. A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. J Nucl Med. 1993 Nov; 34(11):2038-43.
Hoh CK, Dahlbom M, Harris G, Choi Y, Hawkins RA, Phelps ME, Maddahi J. Automated iterative three-dimensional registration of positron emission tomography images. J Nucl Med. 1993 Nov; 34(11):2009-18.
Karlan BY, Hawkins R, Hoh C, Lee M, Tse N, Cane P, Glaspy J. Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol. 1993 Nov; 51(2):175-81.
Messa C, Goodman WG, Hoh CK, Choi Y, Nissenson AR, Salusky IB, Phelps ME, Hawkins RA. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab. 1993 Oct; 77(4):949-55.
Chaiken L, Rege S, Hoh C, Choi Y, Jabour B, Juillard G, Hawkins R, Parker R. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys. 1993 Sep 30; 27(2):455-64.
Thompson AM, Hawkins RA, Elton RA, Steel CM, Chetty U, Carter DC. pS2 is an independent factor of good prognosis in primary breast cancer. Br J Cancer. 1993 Jul; 68(1):93-6.
Rege SD, Hoh CK, Glaspy JA, Aberle DR, Dahlbom M, Razavi MK, Phelps ME, Hawkins RA. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer. 1993 Jul 01; 72(1):82-90.
Lee TH, Anzai Y, Huda A, Rege S, Hawkins R, Lufkin RB. Positron emission tomographic imaging of the head and neck. West J Med. 1993 Jul; 159(1):72.
Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology (Williston Park). 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55.
Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, Schiepers C, Choi Y, Rege S, Nitzsche E. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr. 1993 Jul-Aug; 17(4):582-9.
Llacer J, Veklerov E, Baxter LR, Grafton ST, Griffeth LK, Hawkins RA, Hoh CK, Mazziotta JC, Hoffman EJ, Metz CE. Results of a clinical receiver operating characteristic study comparing filtered backprojection and maximum likelihood estimator images in FDG PET studies. J Nucl Med. 1993 Jul; 34(7):1198-203.
Hawkins RA, Choi Y, Scates S, Rege S, Hoh CK, Glaspy J, Phelps ME. An animal model for in vivo evaluation of tumor glycolytic rates with positron emission tomography. J Surg Oncol. 1993 Jun; 53(2):104-9.
Karlan BY, Hoh C, Tse N, Futoran R, Hawkins R, Glaspy J. Whole-body positron emission tomography with (fluorine-18)-2-deoxyglucose can detect metastatic carcinoma of the fallopian tube. Gynecol Oncol. 1993 Jun; 49(3):383-8.
Nitzsche EU, Hoh CK, Dalbohm NM, Glaspy JA, Phelps ME, Moser EA, Hawkins RA. [Whole body positron emission tomography in breast cancer]. Rofo. 1993 Apr; 158(4):293-8.
Nitzsche EU, Zimmerhackl LB, Hawkins RA, Stöver B, Frankenschmidt A, Sigmund G, Choi Y, Hoh CK, Moser EA. Correlation of ultrasound and renal scintigraphy in children with unilateral hydronephrosis in primary workup. Pediatr Nephrol. 1993 Apr; 7(2):138-42.
Choi Y, Brunken RC, Hawkins RA, Huang SC, Buxton DB, Hoh CK, Phelps ME, Schelbert HR. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med. 1993 Apr; 20(4):308-18.
Choi Y, Huang SC, Hawkins RA, Kuhle WG, Dahlbom M, Hoh CK, Czernin J, Phelps ME, Schelbert HR. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med. 1993 Mar; 34(3):488-97.
Blackwell KE, Castro DJ, Saxton RE, Nyerges A, Calcaterra TC, Schiller V, Grant E, Soudant J, Hirschowitz S, Hawkins R. MRI and ultrasound guided interstitial Nd:YAG laser phototherapy for palliative treatment of advanced head and neck tumors: clinical experience. J Clin Laser Med Surg. 1993 Feb; 11(1):7-14.
Hoh CK, Hawkins RA, Dahlbom M, Glaspy JA, Seeger LL, Choi Y, Schiepers CW, Huang SC, Satyamurthy N, Barrio JR. Whole body skeletal imaging with [18F]fluoride ion and PET. J Comput Assist Tomogr. 1993 Jan-Feb; 17(1):34-41.
Dorward NL, Hawkins RA, Whittle IR. Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma. Br J Neurosurg. 1993; 7(2):197-9.
Chen BC, Germano G, Huang SC, Hawkins RA, Hansen HW, Robert MJ, Buxton DB, Schelbert HR, Kurtz I, Phelps ME. A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. J Am Soc Nephrol. 1992 Dec; 3(6):1295-306.
Brunken RC, Mody FV, Hawkins RA, Nienaber C, Phelps ME, Schelbert HR. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects. Circulation. 1992 Nov; 86(5):1357-69.
Hawkins RA, Hoh C, Glaspy J, Choi Y, Dahlbom M, Rege S, Messa C, Nietszche E, Hoffman E, Seeger L. The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med. 1992 Oct; 22(4):268-84.
Messa C, Choi Y, Hoh CK, Jacobs EL, Glaspy JA, Rege S, Nitzsche E, Huang SC, Phelps ME, Hawkins RA. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. J Comput Assist Tomogr. 1992 Sep-Oct; 16(5):684-9.
Tse NY, Hoh CK, Hawkins RA, Zinner MJ, Dahlbom M, Choi Y, Maddahi J, Brunicardi FC, Phelps ME, Glaspy JA. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg. 1992 Jul; 216(1):27-34.
Dahlbom M, Hoffman EJ, Hoh CK, Schiepers C, Rosenqvist G, Hawkins RA, Phelps ME. Whole-body positron emission tomography: Part I. Methods and performance characteristics. J Nucl Med. 1992 Jun; 33(6):1191-9.
Hawkins RA, Choi Y, Huang SC, Hoh CK, Dahlbom M, Schiepers C, Satyamurthy N, Barrio JR, Phelps ME. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med. 1992 May; 33(5):633-42.
Hawkins RA, Choi Y, Huang SC, Messa C, Hoh CK, Phelps ME. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med. 1992 Mar; 33(3):339-44.
Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope. 1992 Mar; 102(3):281-8.
Chen BC, Huang SC, Germano G, Kuhle W, Hawkins RA, Buxton D, Brunken RC, Schelbert HR, Phelps ME. Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. J Nucl Med. 1991 Dec; 32(12):2199-206.
Hawkins RA, Hoh C, Dahlbom M, Choi Y, Glaspy J, Tse N, Slamon D, Chen B, Messa C, Maddahi J. PET cancer evaluations with FDG. J Nucl Med. 1991 Aug; 32(8):1555-8.
Gold RH, Hawkins RA, Katz RD. Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol. 1991 Aug; 157(2):365-70.
Choi Y, Hawkins RA, Huang SC, Gambhir SS, Brunken RC, Phelps ME, Schelbert HR. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med. 1991 Apr; 32(4):733-8.
Hawkins RA, Killen E, Whittle IR, Jack WJ, Chetty U, Prescott RJ. Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance. Br J Cancer. 1991 Apr; 63(4):553-60.
Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S, Hawkins RA, Becker DP. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med. 1990 Jun; 31(6):965-9.
Webber MM, Gomes AS, Roe D, La Fontaine RL, Hawkins RA. Comparison of Biello, McNeil, and PIOPED criteria for the diagnosis of pulmonary emboli on lung scans. AJR Am J Roentgenol. 1990 May; 154(5):975-81.
Guze BH, Webber MM, Hawkins RA, Sinha K. Indium-111 white blood cell scans: sensitivity, specificity, accuracy, and normal patterns of distribution. Clin Nucl Med. 1990 Jan; 15(1):8-10.
Bahn MM, Huang SC, Hawkins RA, Satyamurthy N, Hoffman JM, Barrio JR, Mazziotta JC, Phelps ME. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography. J Cereb Blood Flow Metab. 1989 Dec; 9(6):840-9.
Huang SC, Bahn MM, Barrio JR, Hoffman JM, Satyamurthy N, Hawkins RA, Mazziotta JC, Phelps ME. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography. J Cereb Blood Flow Metab. 1989 Dec; 9(6):850-8.
Loken MK, Hawkins RA, Gupta NC, Frick MP. Positron emission tomography (PET): a unique approach for the imaging of in vivo metabolism. Nebr Med J. 1989 Nov; 74(11):333-9.
Guze BH, Hawkins RA. Utility of the SPECT Tc-99m labeled RBC blood pool scan in the detection of hepatic hemangiomas. Clin Nucl Med. 1989 Nov; 14(11):817-8.
Gambhir SS, Hawkins RA, Huang SC, Hall TR, Busuttil RW, Phelps ME. Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy. J Nucl Med. 1989 Sep; 30(9):1507-18.
Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg. 1989 Sep; 71(3):342-6.
Hawkins RA, Huang SC, Barrio JR, Keen RE, Feng D, Mazziotta JC, Phelps ME. Estimation of local cerebral protein synthesis rates with L-[1-11C]leucine and PET: methods, model, and results in animals and humans. J Cereb Blood Flow Metab. 1989 Aug; 9(4):446-60.
Keen RE, Barrio JR, Huang SC, Hawkins RA, Phelps ME. In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical parameters to structure tracer kinetic models for positron emission tomography. J Cereb Blood Flow Metab. 1989 Aug; 9(4):429-45.
Guze BH, Hawkins RA, Marcus CS. Technetium-99m white blood cell imaging: false-negative result in salmonella osteomyelitis associated with sickle cell disease. Clin Nucl Med. 1989 Feb; 14(2):104-6.
Mut F, Glickman S, Marciano D, Hawkins RA. Optimum processing protocols for volume determination of the liver and spleen from SPECT imaging with technetium-99m sulfur colloid. J Nucl Med. 1988 Nov; 29(11):1768-75.
Whittle IR, Hawkins RA, Killen E, Miller JD. Epidermal growth factor binding in intracranial neoplasms: preliminary biochemical and clinicopathological findings. Br J Neurosurg. 1988; 2(2):211-5.
Brown RK, Gomes A, King W, Pusey E, Lois J, Goldstein L, Busuttil RW, Hawkins RA. Hepatic hemangiomas: evaluation by magnetic resonance imaging and technetium-99m red blood cell scintigraphy. J Nucl Med. 1987 Nov; 28(11):1683-7.
Hawkins RA, Mazziotta JC, Phelps ME. Wilson's disease studied with FDG and positron emission tomography. Neurology. 1987 Nov; 37(11):1707-11.
Whittle IR, Hawkins RA, Miller JD. Sex hormone receptors in intracranial tumours and normal brain. Eur J Surg Oncol. 1987 Aug; 13(4):303-7.
Gambhir SS, Huang SC, Hawkins RA, Phelps ME. A study of the single compartment tracer kinetic model for the measurement of local cerebral blood flow using 15O-water and positron emission tomography. J Cereb Blood Flow Metab. 1987 Feb; 7(1):13-20.
Brown RK, Memsic LD, Busuttil RW, Pusey E, Ray RA, Kangarloo H, Hawkins RA. Accurate demonstration of hepatic infarction in liver transplant recipients. J Nucl Med. 1986 Sep; 27(9):1428-31.
Steele RJ, Eremin O, Brown M, Hawkins RA. Oestrogen receptor concentration and macrophage infiltration in human breast cancer. Eur J Surg Oncol. 1986 Sep; 12(3):273-6.
Wilson JA, Hawkins RA, Sangster K, von Haacke NP, Tesdale A, Leese AM, Murray JA, Maran AG. Estimation of oestrogen and progesterone receptors in chronic rhinitis. Clin Otolaryngol Allied Sci. 1986 Aug; 11(4):213-8.
Brown RK, Memsic LD, Pusey EJ, Dietrich RB, Busuttil RW, Hawkins RA, Kangarloo H. Hepatic abscess in liver transplantation. Accurate diagnosis and treatment. Clin Nucl Med. 1986 Apr; 11(4):233-6.
Hawkins RA, Phelps ME, Huang SC. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. J Cereb Blood Flow Metab. 1986 Apr; 6(2):170-83.
Miller WR, Telford J, Dixon JM, Hawkins RA. Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity. Eur J Cancer Clin Oncol. 1985 Apr; 21(4):539-42.
Kuhl DE, Metter EJ, Riege WH, Hawkins RA. Determinations of cerebral glucose utilization in dementia using positron emission tomography. Dan Med Bull. 1985 Feb; 32 Suppl 1:51-5.
Hawkins RA, Phelps ME, Huang SC, Wapenski JA, Grimm PD, Parker RG, Juillard G, Greenberg P. A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography. J Cereb Blood Flow Metab. 1984 Dec; 4(4):507-15.
Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol. 1983 Nov; 40(12):711-4.
Humeniuk V, Forrest AP, Hawkins RA, Prescott R. Elastosis and primary breast cancer. Cancer. 1983 Oct 15; 52(8):1448-52.
Hawkins RA, Mazziotta JC, Phelps ME, Huang SC, Kuhl DE, Carson RE, Metter EJ, Riege WH. Cerebral glucose metabolism as a function of age in man: influence of the rate constants in the fluorodeoxyglucose method. J Cereb Blood Flow Metab. 1983 Jun; 3(2):250-3.
Humeniuk V, Hawkins RA, Prescott RJ, Roberts MM, Stewart HJ, Forrest AP. Oestrogen receptors and primary breast cancer. Aust N Z J Surg. 1982 Aug; 52(4):408-14.
Forrest AP, Black RB, Humeniuk V, Cant EL, Hawkins RA, Prescott RJ, Roberts MM, Shivas AA, Stewart HJ, Smith AF, Sumerling M, Sumerling M. Preoperative assessment and staging of breast cancer: preliminary communication. J R Soc Med. 1980 Aug; 73(8):561-6.
Penney GC, Scott KM, Hawkins RA. Endogenous peroxidase: an alternative to oestrogen receptor in the management of breast cancer? Br J Cancer. 1980 Apr; 41(4):648-51.
Mans AM, Biebuyck JF, Saunders SJ, Kirsch RE, Hawkins RA. Tryptophan transport across the blood-brain barrier during acute hepatic failure. J Neurochem. 1979 Aug; 33(2):409-18.
Scott AM, Murphy S, Hawkins RA. Synthesis of DNA and lecithin in tissue culture and oestrogen receptor activity in rat mammary tumours dependent on and independent of the ovary. J Endocrinol. 1979 May; 81(2):183-98.